| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.67e-05 | 124 | 134 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.98e-05 | 51 | 134 | 5 | GO:0050919 | |
| GeneOntologyCellularComponent | integrin alphaIIb-beta3 complex | 1.27e-04 | 3 | 137 | 2 | GO:0070442 | |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 1.27e-04 | 3 | 137 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | lamellipodium | 1.41e-04 | 230 | 137 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | cell leading edge | EPS8L2 ATP7A CDC42BPA MYLK CD177 APP ITGB1 ITGB3 TLN1 UNC5C PLCE1 | 4.63e-04 | 500 | 137 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.08e-04 | 59 | 137 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | Golgi lumen | 7.61e-04 | 109 | 137 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | secretory granule | ATP7A CD177 SFTPB SH3GL3 DCST2 ITGA2B APP TUBA8 ITGB1 ITGB3 GHRHR IGF2R AGL CD58 KLK9 SSH2 | 1.00e-03 | 1014 | 137 | 16 | GO:0030141 |
| GeneOntologyCellularComponent | integrin complex | 1.19e-03 | 32 | 137 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 CILP SFTPB LAMC1 MUC5B F2 ITGB1 FBN2 ADAMTS6 ADAMTS9 OTOGL FBN3 | 1.29e-03 | 656 | 137 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 CILP SFTPB LAMC1 MUC5B F2 ITGB1 FBN2 ADAMTS6 ADAMTS9 OTOGL FBN3 | 1.33e-03 | 658 | 137 | 12 | GO:0030312 |
| MousePheno | internal hemorrhage | SMG1 HSPG2 ATP7A LAMC1 ITGA2B APP F2 ITGB3 DZANK1 IGF2R JAG1 SLIT3 TONSL | 1.44e-05 | 387 | 113 | 13 | MP:0001634 |
| MousePheno | centrally nucleated skeletal muscle fibers | 4.51e-05 | 80 | 113 | 6 | MP:0009404 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 5.47e-05 | 212 | 113 | 9 | MP:0003084 | |
| MousePheno | abnormal skeletal muscle morphology | HSPG2 ATP7A INHBB SGCB LAMC1 VPS54 APP ITGB1 CD163 KLHL31 HOXA2 FBN2 AGL SLIT3 | 5.92e-05 | 508 | 113 | 14 | MP:0000759 |
| MousePheno | abnormal muscle morphology | HSPG2 ATP7A INHBB SGCB BACH1 LAMC1 VPS54 BCL6 APP ITGB1 ITGB3 ZNF416 ARAF CD163 KLHL31 HOXA2 TNNI3K FBN2 IGF2R ADAMTS6 AGL SLIT3 | 6.47e-05 | 1106 | 113 | 22 | MP:0002108 |
| MousePheno | hemorrhage | PCSK5 SMG1 HSPG2 ATP7A LAMC1 ITGA2B APP F2 ITGB1 ITGB3 DZANK1 ARNT IGF2R JAG1 SLIT3 TONSL | 8.43e-05 | 664 | 113 | 16 | MP:0001914 |
| Domain | Growth_fac_rcpt_ | 1.88e-06 | 156 | 134 | 9 | IPR009030 | |
| Domain | TSP_1 | 5.92e-06 | 63 | 134 | 6 | PF00090 | |
| Domain | TSP1 | 7.11e-06 | 65 | 134 | 6 | SM00209 | |
| Domain | TSP1_rpt | 7.11e-06 | 65 | 134 | 6 | IPR000884 | |
| Domain | TSP1 | 7.11e-06 | 65 | 134 | 6 | PS50092 | |
| Domain | UPAR_LY6 | 1.12e-05 | 20 | 134 | 4 | PF00021 | |
| Domain | PSI | 1.53e-05 | 44 | 134 | 5 | IPR016201 | |
| Domain | LY6_UPA_recep-like | 1.68e-05 | 22 | 134 | 4 | IPR016054 | |
| Domain | PSI | 1.91e-05 | 46 | 134 | 5 | SM00423 | |
| Domain | EGF_1 | 9.47e-05 | 255 | 134 | 9 | PS00022 | |
| Domain | EGF-like_CS | 1.13e-04 | 261 | 134 | 9 | IPR013032 | |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 1.53e-04 | 3 | 134 | 2 | IPR000573 | |
| Domain | Aconitase_C | 1.53e-04 | 3 | 134 | 2 | PF00694 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 3.30.499.10 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 1.53e-04 | 3 | 134 | 2 | IPR001030 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 3.40.1060.10 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 1.53e-04 | 3 | 134 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 1.53e-04 | 3 | 134 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 1.53e-04 | 3 | 134 | 2 | IPR015932 | |
| Domain | ACONITASE_1 | 1.53e-04 | 3 | 134 | 2 | PS00450 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 1.53e-04 | 3 | 134 | 2 | IPR015928 | |
| Domain | Aconitase | 1.53e-04 | 3 | 134 | 2 | PF00330 | |
| Domain | Aconitase_4Fe-4S_BS | 1.53e-04 | 3 | 134 | 2 | IPR018136 | |
| Domain | ACONITASE_2 | 1.53e-04 | 3 | 134 | 2 | PS01244 | |
| Domain | FBN | 1.53e-04 | 3 | 134 | 2 | IPR011398 | |
| Domain | EGF_CA | 2.49e-04 | 122 | 134 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.72e-04 | 124 | 134 | 6 | IPR001881 | |
| Domain | EGF | 2.98e-04 | 235 | 134 | 8 | SM00181 | |
| Domain | - | 3.04e-04 | 4 | 134 | 2 | 1.20.5.630 | |
| Domain | EGF-like_dom | 4.39e-04 | 249 | 134 | 8 | IPR000742 | |
| Domain | EGF_2 | 6.61e-04 | 265 | 134 | 8 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 6.70e-04 | 97 | 134 | 5 | IPR018097 | |
| Domain | EGF_CA | 7.35e-04 | 99 | 134 | 5 | PS01187 | |
| Domain | Integrin_dom | 7.40e-04 | 25 | 134 | 3 | IPR032695 | |
| Domain | GAT_dom | 7.52e-04 | 6 | 134 | 2 | IPR004152 | |
| Domain | Integrin_b_cyt | 7.52e-04 | 6 | 134 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 7.52e-04 | 6 | 134 | 2 | PF08725 | |
| Domain | - | 7.52e-04 | 6 | 134 | 2 | 1.20.58.160 | |
| Domain | SWIRM | 7.52e-04 | 6 | 134 | 2 | PS50934 | |
| Domain | Integrin_bsu_cyt_dom | 7.52e-04 | 6 | 134 | 2 | IPR014836 | |
| Domain | GAT | 7.52e-04 | 6 | 134 | 2 | PS50909 | |
| Domain | SWIRM | 7.52e-04 | 6 | 134 | 2 | PF04433 | |
| Domain | SWIRM | 7.52e-04 | 6 | 134 | 2 | IPR007526 | |
| Domain | WxxW_domain | 7.52e-04 | 6 | 134 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.52e-04 | 6 | 134 | 2 | PF13330 | |
| Domain | GAT | 7.52e-04 | 6 | 134 | 2 | PF03127 | |
| Domain | cEGF | 8.32e-04 | 26 | 134 | 3 | PF12662 | |
| Domain | cEGF | 8.32e-04 | 26 | 134 | 3 | IPR026823 | |
| Domain | IPT | 9.31e-04 | 27 | 134 | 3 | SM00429 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.00e-03 | 106 | 134 | 5 | IPR000152 | |
| Domain | hEGF | 1.04e-03 | 28 | 134 | 3 | PF12661 | |
| Domain | TB | 1.05e-03 | 7 | 134 | 2 | PF00683 | |
| Domain | Integrin_B_tail | 1.05e-03 | 7 | 134 | 2 | SM01242 | |
| Domain | Integrin_bsu_tail | 1.05e-03 | 7 | 134 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.05e-03 | 7 | 134 | 2 | PF07965 | |
| Domain | - | 1.39e-03 | 8 | 134 | 2 | 3.90.290.10 | |
| Domain | INB | 1.39e-03 | 8 | 134 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.39e-03 | 8 | 134 | 2 | IPR002369 | |
| Domain | Integrin_beta | 1.39e-03 | 8 | 134 | 2 | PF00362 | |
| Domain | LAMININ_IVA | 1.39e-03 | 8 | 134 | 2 | PS51115 | |
| Domain | Laminin_B | 1.39e-03 | 8 | 134 | 2 | PF00052 | |
| Domain | LamB | 1.39e-03 | 8 | 134 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.39e-03 | 8 | 134 | 2 | IPR000034 | |
| Domain | Semap_dom | 1.40e-03 | 31 | 134 | 3 | IPR001627 | |
| Domain | SEMA | 1.40e-03 | 31 | 134 | 3 | PS51004 | |
| Domain | TIG | 1.40e-03 | 31 | 134 | 3 | PF01833 | |
| Domain | Sema | 1.40e-03 | 31 | 134 | 3 | SM00630 | |
| Domain | Sema | 1.40e-03 | 31 | 134 | 3 | PF01403 | |
| Domain | IPT | 1.54e-03 | 32 | 134 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 1.54e-03 | 32 | 134 | 3 | IPR002165 | |
| Domain | PSI | 1.54e-03 | 32 | 134 | 3 | PF01437 | |
| Domain | Plexin_cytopl | 1.78e-03 | 9 | 134 | 2 | PF08337 | |
| Domain | Integrin_bsu | 1.78e-03 | 9 | 134 | 2 | IPR015812 | |
| Domain | VHS | 1.78e-03 | 9 | 134 | 2 | PS50179 | |
| Domain | TB_dom | 1.78e-03 | 9 | 134 | 2 | IPR017878 | |
| Domain | INTEGRIN_BETA | 1.78e-03 | 9 | 134 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.78e-03 | 9 | 134 | 2 | PF17205 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.78e-03 | 9 | 134 | 2 | IPR013548 | |
| Domain | Plexin | 1.78e-03 | 9 | 134 | 2 | IPR031148 | |
| Domain | Integin_beta_N | 1.78e-03 | 9 | 134 | 2 | IPR033760 | |
| Domain | VHS | 1.78e-03 | 9 | 134 | 2 | PF00790 | |
| Domain | TB | 1.78e-03 | 9 | 134 | 2 | PS51364 | |
| Domain | VHS | 1.78e-03 | 9 | 134 | 2 | SM00288 | |
| Domain | VHS_dom | 1.78e-03 | 9 | 134 | 2 | IPR002014 | |
| Domain | EGF | 2.15e-03 | 126 | 134 | 5 | PF00008 | |
| Domain | EGF_CA | 3.42e-03 | 86 | 134 | 4 | PF07645 | |
| Domain | PMG | 3.78e-03 | 13 | 134 | 2 | PF05287 | |
| Domain | KRTAP_PMG | 3.78e-03 | 13 | 134 | 2 | IPR007951 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.39e-03 | 14 | 134 | 2 | PS00941 | |
| Domain | COesterase | 4.39e-03 | 14 | 134 | 2 | PF00135 | |
| Domain | PLAC | 4.39e-03 | 14 | 134 | 2 | PF08686 | |
| Domain | CarbesteraseB | 4.39e-03 | 14 | 134 | 2 | IPR002018 | |
| Domain | LU | 5.74e-03 | 16 | 134 | 2 | SM00134 | |
| Domain | ASX_HYDROXYL | 5.84e-03 | 100 | 134 | 4 | PS00010 | |
| Domain | EGF_3 | 7.03e-03 | 235 | 134 | 6 | PS50026 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.01e-05 | 76 | 104 | 6 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 6.61e-05 | 30 | 104 | 4 | M47724 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 8.18e-05 | 12 | 104 | 3 | MM1525 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.93e-05 | 143 | 104 | 7 | M27275 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.07e-04 | 64 | 104 | 5 | M7923 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.32e-04 | 261 | 104 | 9 | MM15676 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 1.34e-04 | 14 | 104 | 3 | M13143 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.43e-04 | 68 | 104 | 5 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.53e-04 | 109 | 104 | 6 | MM15164 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.53e-04 | 37 | 104 | 4 | M27134 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.66e-04 | 15 | 104 | 3 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.66e-04 | 15 | 104 | 3 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.66e-04 | 15 | 104 | 3 | MM14959 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.66e-04 | 15 | 104 | 3 | MM14961 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.69e-04 | 111 | 104 | 6 | M27416 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.70e-04 | 38 | 104 | 4 | MM15456 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.88e-04 | 72 | 104 | 5 | M39403 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.89e-04 | 39 | 104 | 4 | MM15272 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.89e-04 | 39 | 104 | 4 | M10735 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-04 | 39 | 104 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.89e-04 | 39 | 104 | 4 | MM15165 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.00e-04 | 73 | 104 | 5 | MM15906 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.08e-04 | 40 | 104 | 4 | M27557 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.02e-04 | 44 | 104 | 4 | M26969 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 3.30e-04 | 45 | 104 | 4 | M27623 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.47e-04 | 19 | 104 | 3 | M10959 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 3.47e-04 | 19 | 104 | 3 | MM15113 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 3.47e-04 | 19 | 104 | 3 | MM1434 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.72e-04 | 300 | 104 | 9 | M610 | |
| Pathway | KEGG_AXON_GUIDANCE | 3.81e-04 | 129 | 104 | 6 | M5539 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.86e-04 | 84 | 104 | 5 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.91e-04 | 47 | 104 | 4 | MM14925 | |
| Pathway | WP_FOCAL_ADHESION | 4.64e-04 | 187 | 104 | 7 | MM15913 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 4.71e-04 | 21 | 104 | 3 | MM1390 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 4.71e-04 | 21 | 104 | 3 | M878 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.20e-04 | 250 | 104 | 8 | M27554 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 5.35e-04 | 51 | 104 | 4 | MM14967 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 6.20e-04 | 23 | 104 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 6.20e-04 | 23 | 104 | 3 | M47720 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 8.96e-04 | 26 | 104 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 8.96e-04 | 26 | 104 | 3 | M47719 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.32e-04 | 59 | 104 | 4 | M27218 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 9.38e-04 | 102 | 104 | 5 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 9.38e-04 | 102 | 104 | 5 | MM15830 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.00e-03 | 213 | 104 | 7 | M18306 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 1.00e-03 | 27 | 104 | 3 | M760 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | LAMC1 SEMA5A ITGA2B TUBA8 ITGB1 ITGB3 HOXA2 TLN1 UNC5C SLIT3 PLXNA4 PLXNB1 | 1.07e-03 | 575 | 104 | 12 | M29853 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.12e-03 | 28 | 104 | 3 | M47655 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 1.12e-03 | 28 | 104 | 3 | MM14958 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP12-2 SEMA5A ITGA2B TUBA8 ITGB1 ITGB3 KRT76 TLN1 SLIT3 PLXNA4 PLXNB1 | 1.18e-03 | 502 | 104 | 11 | MM14537 |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 1.34e-03 | 65 | 104 | 4 | M38994 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.37e-03 | 30 | 104 | 3 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 1.37e-03 | 30 | 104 | 3 | M47718 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.58e-03 | 68 | 104 | 4 | MM14968 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.66e-03 | 32 | 104 | 3 | MM14854 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.88e-03 | 9 | 104 | 2 | MM15030 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.88e-03 | 9 | 104 | 2 | M47725 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.00e-03 | 121 | 104 | 5 | M872 | |
| Pathway | PID_ARF6_PATHWAY | 2.15e-03 | 35 | 104 | 3 | M86 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.17e-03 | 74 | 104 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.17e-03 | 74 | 104 | 4 | M39462 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | AMFR USP30 THSD7A LAMC1 SEMA5A MUC5B XPNPEP2 APP TUBA8 F2 MYSM1 TMEM129 GPIHBP1 ADAMTS6 ICMT ADAMTS9 ST6GALNAC4 NR3C2 KDM1B LY6E MPI | 2.30e-03 | 1475 | 104 | 21 | M19806 |
| Pubmed | Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. | 1.15e-09 | 5 | 137 | 4 | 18086863 | |
| Pubmed | Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. | 5.98e-08 | 3 | 137 | 3 | 18573917 | |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 24677266 | ||
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 11412103 | ||
| Pubmed | The structure of the talin/integrin complex at a lipid bilayer: an NMR and MD simulation study. | 5.98e-08 | 3 | 137 | 3 | 20947017 | |
| Pubmed | TA205, an anti-talin monoclonal antibody, inhibits integrin-talin interaction. | 5.98e-08 | 3 | 137 | 3 | 16546176 | |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 8663236 | ||
| Pubmed | 8.21e-08 | 257 | 137 | 10 | 16335952 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 22015659 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 27929375 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 16720835 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 12799374 | ||
| Pubmed | Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke. | 2.38e-07 | 4 | 137 | 3 | 18383324 | |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 15978110 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 23022222 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 21134644 | ||
| Pubmed | Kindlin-3 is essential for integrin activation and platelet aggregation. | 2.38e-07 | 4 | 137 | 3 | 18278053 | |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 24585775 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 17538005 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 19805288 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 19843520 | ||
| Pubmed | Basic amino-acid side chains regulate transmembrane integrin signalling. | 5.95e-07 | 5 | 137 | 3 | 22178926 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 6.75e-07 | 18 | 137 | 4 | 39040056 | |
| Pubmed | SMG1 HSPG2 CDC42BPA SGCB LAMC1 BCL6 ANKRD50 ITGB1 ADAMTS9 AGL TLN1 PLCE1 | 7.03e-07 | 497 | 137 | 12 | 23414517 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 EPS8L2 CILP CD177 ACAT1 TOM1L1 LAMC1 SEMA5A MUC5B F2 ITGB1 KRT76 IGF2R TLN1 KRT37 CDH11 MPI | 1.15e-06 | 1070 | 137 | 17 | 23533145 |
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 16357324 | ||
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 22461623 | ||
| Pubmed | Involvement of transmembrane domain interactions in signal transduction by alpha/beta integrins. | 1.19e-06 | 6 | 137 | 3 | 14681217 | |
| Pubmed | CD36 associates with CD9 and integrins on human blood platelets. | 1.19e-06 | 6 | 137 | 3 | 11238109 | |
| Pubmed | 1.62e-06 | 50 | 137 | 5 | 23658023 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 1.93e-06 | 23 | 137 | 4 | 23152823 | |
| Pubmed | Association of human platelet alloantigen 1 through 5 polymorphisms with ischemic stroke. | 2.07e-06 | 7 | 137 | 3 | 18057877 | |
| Pubmed | The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. | 2.07e-06 | 7 | 137 | 3 | 37184585 | |
| Pubmed | 3.22e-06 | 26 | 137 | 4 | 23382103 | ||
| Pubmed | 3.30e-06 | 8 | 137 | 3 | 8631894 | ||
| Pubmed | 3.30e-06 | 8 | 137 | 3 | 27221710 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 3.77e-06 | 27 | 137 | 4 | 31541017 | |
| Pubmed | 4.38e-06 | 28 | 137 | 4 | 18617019 | ||
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 11807098 | ||
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 7.03e-06 | 10 | 137 | 3 | 16554364 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KDM5D ITGB3 TASOR2 KRT76 TLN1 PIP4P1 TONSL ATF7IP2 UNK SPRTN | 8.54e-06 | 430 | 137 | 10 | 35044719 |
| Pubmed | 9.64e-06 | 11 | 137 | 3 | 34910918 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 9.64e-06 | 11 | 137 | 3 | 36792666 | |
| Pubmed | 1.28e-05 | 12 | 137 | 3 | 19693543 | ||
| Pubmed | 1.28e-05 | 12 | 137 | 3 | 12606711 | ||
| Pubmed | 1.28e-05 | 12 | 137 | 3 | 16024816 | ||
| Pubmed | Organization, evolution and functions of the human and mouse Ly6/uPAR family genes. | 1.53e-05 | 38 | 137 | 4 | 27098205 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 34089379 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22015616 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11279249 | ||
| Pubmed | Tickling the tails: cytoplasmic domain proteins that regulate integrin alphaIIbbeta3 activation. | 1.54e-05 | 2 | 137 | 2 | 17414216 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24096143 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22136613 | ||
| Pubmed | Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation. | 1.54e-05 | 2 | 137 | 2 | 28790378 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24474638 | ||
| Pubmed | Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. | 1.54e-05 | 2 | 137 | 2 | 21368290 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26350460 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 2018971 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 27965976 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 38579706 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20584077 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18405917 | ||
| Pubmed | Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. | 1.54e-05 | 2 | 137 | 2 | 25373348 | |
| Pubmed | β3 integrin is dispensable for conditioned fear and hebbian forms of plasticity in the hippocampus. | 1.54e-05 | 2 | 137 | 2 | 22748100 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26301697 | ||
| Pubmed | Glanzmann thrombasthenia: state of the art and future directions. | 1.54e-05 | 2 | 137 | 2 | 23929305 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22448399 | ||
| Pubmed | Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis. | 1.54e-05 | 2 | 137 | 2 | 22484027 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22531012 | ||
| Pubmed | AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3. | 1.54e-05 | 2 | 137 | 2 | 18791937 | |
| Pubmed | Potential Mechanism of Platelet GPIIb/IIIa and Fibrinogen on Retinal Vein Occlusion. | 1.54e-05 | 2 | 137 | 2 | 38482878 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17032655 | ||
| Pubmed | The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen. | 1.54e-05 | 2 | 137 | 2 | 26867579 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17332246 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18174155 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19329429 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20020534 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20308600 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 16359515 | ||
| Pubmed | Electron tomography reveals diverse conformations of integrin alphaIIbbeta3 in the active state. | 1.54e-05 | 2 | 137 | 2 | 15890274 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22511753 | ||
| Pubmed | Iron regulatory protein 2 is involved in brain copper homeostasis. | 1.54e-05 | 2 | 137 | 2 | 19584448 | |
| Pubmed | Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes. | 1.54e-05 | 2 | 137 | 2 | 17561290 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26359510 | ||
| Pubmed | Activation induced morphological changes and integrin αIIbβ3 activity of living platelets. | 1.54e-05 | 2 | 137 | 2 | 23571313 | |
| Pubmed | The phosphotyrosine binding-like domain of talin activates integrins. | 1.54e-05 | 2 | 137 | 2 | 11932255 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32089034 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12871468 | ||
| Pubmed | The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. | 1.54e-05 | 2 | 137 | 2 | 12690105 | |
| Pubmed | Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. | 1.54e-05 | 2 | 137 | 2 | 7878622 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18573216 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31618629 | ||
| Pubmed | Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3. | 1.54e-05 | 2 | 137 | 2 | 20363746 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32344835 | ||
| Pubmed | Regulation of integrin alphaIIbbeta3 activation by distinct regions of its cytoplasmic tails. | 1.54e-05 | 2 | 137 | 2 | 16716076 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19527732 | ||
| Pubmed | Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. | 1.54e-05 | 2 | 137 | 2 | 11606749 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19262211 | ||
| Pubmed | β1A integrin is a master regulator of invadosome organization and function. | 1.54e-05 | 2 | 137 | 2 | 20926684 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11858493 | ||
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 3.32e-05 | 34 | 98 | 4 | 1226 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.02e-03 | 9 | 98 | 2 | 1159 | |
| GeneFamily | Plexins | 1.02e-03 | 9 | 98 | 2 | 683 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.35e-03 | 394 | 98 | 8 | 471 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | PINLYP CDC42BPA CD177 ITGA2B KDM5D ANKRD50 APP ITGB3 CD163 RUSC2 GTF3C2 TONSL TLE6 ST6GALNAC4 KRT37 PLCE1 | 1.42e-06 | 746 | 134 | 16 | M40863 |
| Coexpression | STREICHER_LSM1_TARGETS_UP | 3.00e-06 | 44 | 134 | 5 | M15031 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 9.16e-06 | 200 | 134 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME | PCSK5 HSPG2 CILP SFTPB INHBB LAMC1 SEMA5A MUC5B F2 FNDC7 FBN2 ADAMTS6 ADAMTS9 OTOGL SLIT3 PLXNA4 PLXNB1 | 1.58e-05 | 1008 | 134 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 HSPG2 CILP SFTPB INHBB LAMC1 SEMA5A MUC5B F2 FNDC7 FBN2 ADAMTS6 ADAMTS9 SLIT3 PLXNA4 FBN3 PLXNB1 | 1.98e-05 | 1026 | 134 | 17 | M5889 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.41e-05 | 166 | 134 | 7 | M1542 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | HSPG2 MYLK SGCB BACH1 SLCO3A1 LAMC1 SEMA5A ITGB1 RUSC2 JAG1 SLIT3 | 3.70e-05 | 479 | 134 | 11 | M2573 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.90e-05 | 179 | 134 | 7 | MM660 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | HSPG2 MYLK SGCB BACH1 SLCO3A1 LAMC1 SEMA5A ITGB1 RUSC2 JAG1 SLIT3 | 3.99e-05 | 483 | 134 | 11 | MM1082 |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.76e-05 | 126 | 134 | 6 | M39132 | |
| Coexpression | RPS14_DN.V1_UP | 5.88e-05 | 191 | 134 | 7 | M2816 | |
| Coexpression | GSE13229_IMM_VS_INTMATURE_NKCELL_UP | 7.86e-05 | 200 | 134 | 7 | M3209 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 7.86e-05 | 200 | 134 | 7 | M7469 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-08 | 181 | 136 | 8 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-07 | 195 | 136 | 8 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-07 | 195 | 136 | 8 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.85e-07 | 199 | 136 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 165 | 136 | 7 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 165 | 136 | 7 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 183 | 136 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-06 | 186 | 136 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.78e-06 | 187 | 136 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 187 | 136 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 189 | 136 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 190 | 136 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-06 | 191 | 136 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-06 | 191 | 136 | 7 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.05e-06 | 191 | 136 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.27e-06 | 194 | 136 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-06 | 194 | 136 | 7 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-06 | 194 | 136 | 7 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 194 | 136 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 194 | 136 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.35e-06 | 195 | 136 | 7 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.35e-06 | 195 | 136 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.35e-06 | 195 | 136 | 7 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 197 | 136 | 7 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.60e-06 | 198 | 136 | 7 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | 368C-Endothelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 198 | 136 | 7 | 9a2c2201baee51581733e183065298a97eba4553 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.69e-06 | 199 | 136 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 161 | 136 | 6 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.14e-05 | 164 | 136 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 166 | 136 | 6 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.22e-05 | 166 | 136 | 6 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 169 | 136 | 6 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.44e-05 | 171 | 136 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 175 | 136 | 6 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 175 | 136 | 6 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 178 | 136 | 6 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 178 | 136 | 6 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-05 | 179 | 136 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 179 | 136 | 6 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-05 | 179 | 136 | 6 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 180 | 136 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 181 | 136 | 6 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.99e-05 | 181 | 136 | 6 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 181 | 136 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 183 | 136 | 6 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.12e-05 | 183 | 136 | 6 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 2.12e-05 | 183 | 136 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 183 | 136 | 6 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-05 | 183 | 136 | 6 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 183 | 136 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-05 | 183 | 136 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-05 | 183 | 136 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 184 | 136 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 2.18e-05 | 184 | 136 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 185 | 136 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 185 | 136 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.25e-05 | 185 | 136 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 136 | 6 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 136 | 6 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 186 | 136 | 6 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 2.32e-05 | 186 | 136 | 6 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.32e-05 | 186 | 136 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 2.39e-05 | 187 | 136 | 6 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 2.46e-05 | 188 | 136 | 6 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 189 | 136 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-05 | 190 | 136 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.61e-05 | 190 | 136 | 6 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 190 | 136 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-05 | 190 | 136 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 191 | 136 | 6 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-05 | 191 | 136 | 6 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-05 | 191 | 136 | 6 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 191 | 136 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-05 | 191 | 136 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 192 | 136 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 192 | 136 | 6 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 192 | 136 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-05 | 192 | 136 | 6 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.77e-05 | 192 | 136 | 6 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 192 | 136 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.77e-05 | 192 | 136 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 192 | 136 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 192 | 136 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 2.85e-05 | 193 | 136 | 6 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.85e-05 | 193 | 136 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-05 | 193 | 136 | 6 | 7c0d84b92470bfda2db1e5007feee7c1235a0a78 | |
| Drug | decoxymethanol | 4.06e-06 | 70 | 137 | 6 | CID004629337 | |
| Drug | eptifibatide | 4.21e-06 | 6 | 137 | 3 | ctd:C086648 | |
| Drug | Grgesp | 5.21e-06 | 42 | 137 | 5 | CID000492974 | |
| Drug | NSC135065 | 1.17e-05 | 8 | 137 | 3 | CID000282014 | |
| Drug | Rgd Peptide | 1.49e-05 | 239 | 137 | 9 | CID000104802 | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 1.88e-05 | 188 | 137 | 8 | 4456_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.63e-05 | 197 | 137 | 8 | 2267_DN | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 6426_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 3523_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 2.82e-05 | 199 | 137 | 8 | 6093_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HG-U133A | 2.93e-05 | 200 | 137 | 8 | 1899_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.93e-05 | 200 | 137 | 8 | 6029_UP | |
| Drug | 17-hydroxywortmannin | 3.39e-05 | 11 | 137 | 3 | CID000130966 | |
| Drug | Ro 44-9883 | 3.48e-05 | 31 | 137 | 4 | CID000071453 | |
| Drug | Tirofiban | 3.59e-05 | 2 | 137 | 2 | DB00775 | |
| Drug | SK&F 106760 | 3.59e-05 | 2 | 137 | 2 | ctd:C071275 | |
| Drug | Rgds Peptide | 4.43e-05 | 106 | 137 | 6 | CID000107775 | |
| Disease | Liver Cirrhosis, Experimental | ACAT1 SGCB XPNPEP2 ITGA2B APP ITGB1 ITGB3 CD163 IGF2R CD5L AGL CES3 ADGRE1 ABCG5 | 9.37e-06 | 774 | 131 | 14 | C0023893 |
| Disease | platelet-type bleeding disorder 16 (implicated_via_orthology) | 1.96e-05 | 2 | 131 | 2 | DOID:0060691 (implicated_via_orthology) | |
| Disease | Glanzmann Thrombasthenia, Type A | 1.96e-05 | 2 | 131 | 2 | C3179396 | |
| Disease | platelet-type bleeding disorder 16 (is_implicated_in) | 1.96e-05 | 2 | 131 | 2 | DOID:0060691 (is_implicated_in) | |
| Disease | Glanzmann Thrombasthenia, Autosomal Dominant | 1.96e-05 | 2 | 131 | 2 | C1861195 | |
| Disease | platelet-type bleeding disorder 16 (is_marker_for) | 1.96e-05 | 2 | 131 | 2 | DOID:0060691 (is_marker_for) | |
| Disease | Thrombasthenia | 1.96e-05 | 2 | 131 | 2 | C0040015 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 2.37e-05 | 13 | 131 | 3 | DOID:11758 (biomarker_via_orthology) | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 3.00e-05 | 14 | 131 | 3 | DOID:874 (biomarker_via_orthology) | |
| Disease | Glanzmann's thrombasthenia (is_implicated_in) | 5.85e-05 | 3 | 131 | 2 | DOID:2219 (is_implicated_in) | |
| Disease | connective tissue disease (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | glomerulonephritis (is_marker_for) | 7.87e-05 | 19 | 131 | 3 | DOID:2921 (is_marker_for) | |
| Disease | Alzheimer's Disease | 8.99e-05 | 101 | 131 | 5 | C0002395 | |
| Disease | Internal Carotid Artery Thrombosis | 1.17e-04 | 4 | 131 | 2 | C0750990 | |
| Disease | Common Carotid Artery Thrombosis | 1.17e-04 | 4 | 131 | 2 | C0750988 | |
| Disease | External Carotid Artery Thrombosis | 1.17e-04 | 4 | 131 | 2 | C0750989 | |
| Disease | Carotid Artery Thrombosis | 1.17e-04 | 4 | 131 | 2 | C0007274 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.62e-04 | 24 | 131 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Cerebrovascular accident | 1.70e-04 | 62 | 131 | 4 | C0038454 | |
| Disease | brain measurement, neuroimaging measurement | 1.80e-04 | 550 | 131 | 10 | EFO_0004346, EFO_0004464 | |
| Disease | carbohydrate metabolic disorder (is_implicated_in) | 1.94e-04 | 5 | 131 | 2 | DOID:2978 (is_implicated_in) | |
| Disease | thrombocytopenia (is_implicated_in) | 2.31e-04 | 27 | 131 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 2.90e-04 | 6 | 131 | 2 | C3853779 | |
| Disease | FNAITP | 2.90e-04 | 6 | 131 | 2 | C3854603 | |
| Disease | Autosomal dominant macrothrombocytopenia | 4.05e-04 | 7 | 131 | 2 | C4304021 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 4.05e-04 | 7 | 131 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | cataract | 4.26e-04 | 141 | 131 | 5 | MONDO_0005129 | |
| Disease | Liver carcinoma | 4.52e-04 | 507 | 131 | 9 | C2239176 | |
| Disease | Nerve Degeneration | 5.20e-04 | 83 | 131 | 4 | C0027746 | |
| Disease | bipolar II disorder | 5.38e-04 | 8 | 131 | 2 | EFO_0009964 | |
| Disease | osteosarcoma | 5.38e-04 | 8 | 131 | 2 | EFO_0000637 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_marker_for) | 5.38e-04 | 8 | 131 | 2 | DOID:11266 (is_marker_for) | |
| Disease | uterine fibroid, Menorrhagia | 6.90e-04 | 9 | 131 | 2 | EFO_0000731, HP_0000132 | |
| Disease | Todd Paralysis | 6.90e-04 | 9 | 131 | 2 | C0234544 | |
| Disease | Paralysed | 6.90e-04 | 9 | 131 | 2 | C0522224 | |
| Disease | kynurenine measurement | 6.95e-04 | 39 | 131 | 3 | EFO_0008529 | |
| Disease | Hypercholesterolemia | 6.95e-04 | 39 | 131 | 3 | C0020443 | |
| Disease | cortical surface area measurement | LAMC1 SEMA5A TG FBN2 ACAD11 ADAMTS9 RALGPS1 JAG1 CNKSR3 UNC5C NR3C2 SSH2 CDH11 FBN3 PLCE1 | 9.48e-04 | 1345 | 131 | 15 | EFO_0010736 |
| Disease | Acute Confusional Senile Dementia | 1.01e-03 | 99 | 131 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.01e-03 | 99 | 131 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.01e-03 | 99 | 131 | 4 | C0750901 | |
| Disease | Presenile dementia | 1.01e-03 | 99 | 131 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 1.01e-03 | 99 | 131 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.05e-03 | 100 | 131 | 4 | C0276496 | |
| Disease | corpus callosum volume measurement | 1.05e-03 | 100 | 131 | 4 | EFO_0010299 | |
| Disease | adult respiratory distress syndrome (is_implicated_in) | 1.25e-03 | 12 | 131 | 2 | DOID:11394 (is_implicated_in) | |
| Disease | Cardiomyopathy, Dilated | 1.28e-03 | 48 | 131 | 3 | C0007193 | |
| Disease | hyperglycemia (is_marker_for) | 1.48e-03 | 13 | 131 | 2 | DOID:4195 (is_marker_for) | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 1.61e-03 | 52 | 131 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | open-angle glaucoma | 1.66e-03 | 191 | 131 | 5 | EFO_0004190 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.70e-03 | 53 | 131 | 3 | C4707243 | |
| Disease | Acute Cerebrovascular Accidents | 1.80e-03 | 54 | 131 | 3 | C0751956 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.82e-03 | 195 | 131 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Graves' disease (is_marker_for) | 1.98e-03 | 15 | 131 | 2 | DOID:12361 (is_marker_for) | |
| Disease | intraocular pressure measurement | 2.02e-03 | 509 | 131 | 8 | EFO_0004695 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.25e-03 | 16 | 131 | 2 | C1839071 | |
| Disease | pro-hydroxy-pro measurement | 2.25e-03 | 16 | 131 | 2 | EFO_0021132 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.25e-03 | 16 | 131 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.25e-03 | 16 | 131 | 2 | 415000 | |
| Disease | Astrocytosis | 2.55e-03 | 17 | 131 | 2 | C3887640 | |
| Disease | Moyamoya Disease | 2.55e-03 | 17 | 131 | 2 | C0026654 | |
| Disease | Gliosis | 2.55e-03 | 17 | 131 | 2 | C0017639 | |
| Disease | neuroimaging measurement | CDC42BPA LAMC1 TG FBN2 ACAD11 RALGPS1 JAG1 CNKSR3 SSH2 DMRT1 CDH11 PLCE1 | 2.94e-03 | 1069 | 131 | 12 | EFO_0004346 |
| Disease | diet measurement, HOMA-B | 3.18e-03 | 19 | 131 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 3.53e-03 | 20 | 131 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Hemorrhage | 3.53e-03 | 20 | 131 | 2 | C0019080 | |
| Disease | alcohol consumption measurement | THSD7A ACO2 SEZ6L2 INSYN2A NFATC2 RALGPS1 SPHKAP CNKSR3 PLXNA4 OLFM1 KLF18 NR3C2 CDH11 | 3.60e-03 | 1242 | 131 | 13 | EFO_0007878 |
| Disease | Cardiomyopathies, Primary | 3.62e-03 | 69 | 131 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.62e-03 | 69 | 131 | 3 | C0036529 | |
| Disease | smoking behavior | 4.26e-03 | 341 | 131 | 6 | EFO_0004318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVDSISCTGMATICN | 271 | Q99798 | |
| TSSPNCTDMSNVCQP | 346 | P27540 | |
| CTDMSNVCQPTEFIS | 351 | P27540 | |
| CSTDTPCQMQLSPAV | 406 | O14867 | |
| CSEQAETGPCRAMIS | 291 | P05067 | |
| NESSMPCCVLQLGDI | 61 | Q3LIE5 | |
| MSCSGREATLQDCPS | 206 | O43866 | |
| SNCCNSAVNAPSLVM | 41 | Q9ULJ7 | |
| TTSNTEMCEVGQVCQ | 231 | Q8N6Q3 | |
| ATSTMCVNGVCLNED | 536 | Q75N90 | |
| VCPQCQSTEDAMTVL | 2911 | Q12830 | |
| MGNTLTCCVSPNASP | 1 | Q8N7R7 | |
| MTGTLETQFTCPFCN | 16 | P60002 | |
| SVAGMCEPERSCSIN | 376 | Q9UKP5 | |
| LQGNITSCFCMTEPD | 496 | Q709F0 | |
| MTCNSCVQSIEGVIS | 386 | Q04656 | |
| LNMQHQECGSPCTDT | 331 | Q9HC84 | |
| EVCGPTQFRCVSTNM | 366 | P98160 | |
| CICSLGNSAAVPTME | 421 | Q5JS13 | |
| MQCLSPECSEQPSQT | 311 | Q6ZSG2 | |
| SCTNNCNPSVMLAAG | 511 | P48200 | |
| TDPKFQGQTCEMCQT | 621 | P05556 | |
| NVSLTLDMCTPGCNE | 246 | P54829 | |
| MSGECQSAVCISVVS | 496 | Q01546 | |
| ESPSCLVATMAPCQQ | 716 | Q13469 | |
| GVSCCTLSMPNNVTR | 606 | Q9H511 | |
| GECSCQVSLMLQNSS | 801 | Q15746 | |
| CALTNGSIEVQCMIP | 131 | P19256 | |
| SPSVCSPLNMTSSVC | 191 | P08235 | |
| CCSQNPKASMEEQTS | 31 | P59942 | |
| VEGTQVTMTCCQSSL | 121 | Q8IV16 | |
| VTMTCCQSSLCNVPP | 126 | Q8IV16 | |
| MVECNDTTPACTLSA | 411 | Q5VTL7 | |
| NMSCTPQFITTAPCS | 446 | Q5VTL7 | |
| GCQPVAEANAASMCL | 31 | O76014 | |
| GTVNSCCIPTKLSTM | 366 | P09529 | |
| LMASSPTSICVCGQV | 1166 | Q9BY66 | |
| QGPTQEDCTTCPMTR | 896 | Q92824 | |
| SGTCTTCQKGLIMNP | 1431 | Q92824 | |
| CEVLNATEMTCQAPA | 1086 | Q9HCM2 | |
| SSCPCVESVQGSTLM | 911 | O43157 | |
| GRCICTVVAPQQTMC | 71 | Q99784 | |
| CGAGTCQVIVTTPME | 111 | Q9H936 | |
| LTNLTENGLMCPACT | 116 | A6NC86 | |
| APVTGMVSGQNCCEE | 381 | Q9UJY4 | |
| VVCCAQSVNDPGNMS | 21 | P28472 | |
| CMACSDNTVRAGLTP | 286 | P34949 | |
| MSQSGAVSCCPGATN | 1 | Q9H6S3 | |
| QVDTPIMTKSCVTSC | 346 | Q9NY74 | |
| CSSKVPTVCVDMSTN | 136 | P10398 | |
| CDPETKPTSMQTCQQ | 1091 | Q9P2N4 | |
| KPTSMQTCQQPECAS | 1096 | Q9P2N4 | |
| IGTQVMLCNPICGVS | 221 | O60725 | |
| DCVGMSPSCTSTNRA | 226 | Q8NB78 | |
| QAVTAASTCCPQMPL | 411 | Q8N8A6 | |
| PMSSTNTLTIKVCGC | 581 | P55287 | |
| TCGSSNVSVTTNPMC | 586 | Q9H222 | |
| SGNLNCDPIAMSQCS | 1846 | Q9NSI6 | |
| TSCGSQSPQHAEMCL | 476 | P41182 | |
| CLQAAEEMPNTTLGC | 41 | Q02643 | |
| SSCCPPSVLSGVVQM | 166 | Q5U623 | |
| VNVGVASMGISCCQS | 81 | Q16553 | |
| VSSCQQCLAVSPMCA | 36 | P05106 | |
| NLSQTCVSPGMQCLI | 131 | Q9UKQ9 | |
| CGEQVMTSTGNQALC | 416 | A0A0U1RQI7 | |
| LPVSCQSSVCVPMSF | 56 | P59991 | |
| QSSVCVPMSFKSAVC | 61 | P59991 | |
| TMKQQSSCNPVTGQC | 891 | P11047 | |
| CVSQPCQSESTQQMG | 111 | Q3LI81 | |
| MENTVSCSTPGCQGL | 611 | Q5T1A1 | |
| RPNMCTCSSGQISST | 126 | P35556 | |
| CVTCEGALPSSQESM | 306 | Q9NVP4 | |
| CSSSSPAEMVQCLQQ | 281 | Q6UWW8 | |
| AMCTSCASQTTANDP | 321 | Q99679 | |
| SMEAVSVICNQLGCP | 81 | Q86VB7 | |
| SGSAPMITCRVCQSL | 76 | Q86T03 | |
| NNGSNPCLMTECSGT | 151 | Q9Y5R6 | |
| VMDNGTCISLENCPC | 431 | Q3ZCN5 | |
| DCMSQSPINVASCDG | 2281 | Q3ZCN5 | |
| ICDSSPMLQLSCTNT | 176 | A6NL08 | |
| AVVDIACACSTVPQM | 66 | A4D2G3 | |
| PCEVIDSCTVAMASN | 571 | P78504 | |
| MNDPNSCVDNATVCS | 1 | Q12908 | |
| SPTVPNCLSTMGQNC | 291 | O43364 | |
| TSCVCLPGFQMISNN | 76 | Q5HYA8 | |
| ASTTCPEQMDCSPTA | 226 | Q504T8 | |
| SVDIVQCGPSSAVCM | 71 | P11717 | |
| PVMTLDTQQCGTSHC | 176 | Q8N2Y8 | |
| MCSGPTLLVQESLDC | 1356 | Q2M3C7 | |
| CVTCTDMAVLAGNSG | 256 | Q9NXH9 | |
| IDMCVQNCGPSFQSL | 76 | O75674 | |
| PSIQMRLCCITGSVS | 86 | O14599 | |
| VKTTGSNIPMDQPCC | 276 | Q99963 | |
| QALGVCGTMSSPLQC | 361 | P07988 | |
| SANQLLGMTAIPCAC | 386 | Q9UIG8 | |
| NTSCMVECPVNCQLS | 1276 | Q9UPZ6 | |
| CVTMLCAPLGSVVSN | 96 | Q6ZSM3 | |
| VCPSNSMGSPCIEVD | 1881 | Q9P212 | |
| EELCSMSGNVTCLVQ | 2806 | Q96Q15 | |
| PVKECSSQNVTMSCS | 221 | Q7Z3Q1 | |
| STPCTTINKVCASGM | 116 | P24752 | |
| ETPSCMASCGGTIHN | 341 | Q6UXD5 | |
| TPVSCFNIQMCVGAT | 511 | P08514 | |
| TSQNMGCQISDNPCG | 301 | Q16585 | |
| TTPTKCHQCTSLMVG | 1021 | Q5VT25 | |
| MCETSPILQISCTDT | 176 | A6NF89 | |
| MGSQCSGNTTESRPC | 926 | Q13591 | |
| TEMCPINSTCTNTPG | 226 | Q14246 | |
| QDTSCPTCRMSLNIA | 371 | Q9UKV5 | |
| TACDLTCPMGQVNAD | 201 | O75339 | |
| PCQVQSCQEEMISLG | 396 | Q15003 | |
| RSTTDPVMSQCACLE | 196 | G9CGD6 | |
| RSTTDPVMSQCACLE | 196 | Q6P9H4 | |
| PEQCTCMETVVRCSN | 726 | O75094 | |
| GCMGPITQCTARTQQ | 11 | Q7Z614 | |
| EPCRSCAVVSSSGQM | 71 | Q9H4F1 | |
| ATGPTACPVMQTCSQ | 921 | Q86Y38 | |
| GMCNPEGCLTTHSSI | 821 | Q76I76 | |
| GRSCMIVNVNPCAST | 476 | O95235 | |
| MACQSLGEPGCTQAQ | 1476 | Q9Y490 | |
| LTCMQSCSAPVNAGP | 881 | Q96HA7 | |
| LMQVTCSATGNDSCG | 171 | Q8NE00 | |
| EVRCNCKASTPSMTN | 1581 | Q9HCK1 | |
| IILGEPSCQSCGSEM | 1611 | Q9HCK1 | |
| PSCQSCGSEMNFNVD | 1616 | Q9HCK1 | |
| SSSSQSKMVNCPVCQ | 446 | Q9H040 | |
| MLSCNICGETVTSEP | 1 | Q96AP4 | |
| ASPSTQKIQSCDMCV | 96 | Q9BWM5 | |
| CPICNMTFSSPVVAQ | 136 | Q9UL40 | |
| CSIPVCGQDQVTVAM | 181 | P00734 | |
| TCFMNSLLQGLSACP | 76 | Q70CQ3 | |
| MQATDPSECGQCLSL | 546 | Q8WUA4 | |
| STQGCMCSVVPTLCS | 1646 | Q5VWN6 | |
| NSSCTGPMCVQIEDY | 291 | O43895 | |
| VPSSQELEACIGCMQ | 276 | A0AVI4 | |
| STKCNDMQQSGSCPR | 296 | Q9C0B0 | |
| ECLCNIELMSPASSN | 721 | Q59H18 | |
| CETISGPTGSAMQQC | 1231 | P01266 | |
| NCTDGLCMQTAPDSD | 361 | O95185 | |
| CFMNSSIQCVSNTQP | 541 | P35125 | |
| ITSSCFEPNSQMVKC | 291 | Q9NY65 | |
| EMSPVTCCDVSSNNR | 541 | Q9H808 | |
| CQCVDNIPSVTTDML | 756 | Q9P1Q0 | |
| VTELCNVACSSVMPG | 1101 | Q9H0D2 | |
| LPSTTIVSMACCASG | 641 | P35573 | |
| VESPTCSQMSNLVCG | 41 | O60575 | |
| CSQMSNLVCGTDGLT | 46 | O60575 | |
| CNSLSTGLQCEMDPV | 621 | Q5VVJ2 |